Cancers thrive in microenvironments with widely changing levels of nutrient availability and CO2/HCO3−/pH; therefore, diminished sAC activity, which would uncouple the control sAC has on MAPK activation, may provide a selective advantage for tumor cells. The gene discussed is ADCY10; the disease is cancer.